{
  "url": "https://www.webmd.com/lung-cancer/advances-small-cell-lung-cancer-treatment",
  "title": "Advances in Small-Cell Lung Cancer Treatment",
  "slug": "advances-small-cell-lung-cancer-treatment",
  "published_date": "2024-11-05",
  "first_letter": "A",
  "author": "Kara Mayer Robinson",
  "medically_reviewed_by": "Laura J. Martin, MD",
  "read_time": "4 min read",
  "sections": [
    {
      "heading": null,
      "content": [
        "Until recently, many advancements in treating lung cancer have centered on non-small-cell lung cancer (NSCLC). But new therapies for small-cell lung cancer (SCLC) have started to emerge, and the early results are promising.",
        "SCLC is an aggressive form of lung cancer, and new treatments are key for improving the outlook for people diagnosed with it.",
        "Right now, chemotherapy is the most common treatment for SCLC. There are other options, like surgery and radiation, but they’re limited and their use is controversial. For many people, surgery is not an option if the cancer has spread or the tumor is large or hard to reach.  Often radiation therapy is given at the same time as chemotherapy.",
        "In the last few years, several new treatments were approved by the FDA, including the immunotherapy drugs durvalumab (Imfinzi) and tarlatamab (Imdelltra) and a new chemotherapy drug called lurbinectedin (Zepzelca).",
        "Many clinical trials in the works are studying treatments that may have better results for SCLC.",
        "Here are some of the newest treatments."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "Until recently, many advancements in treating lung cancer have centered on non-small-cell lung cancer (NSCLC). But new therapies for small-cell lung cancer (SCLC) have started to emerge, and the early results are promising.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "SCLC is an aggressive form of lung cancer, and new treatments are key for improving the outlook for people diagnosed with it.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Right now, chemotherapy is the most common treatment for SCLC. There are other options, like surgery and radiation, but they’re limited and their use is controversial. For many people, surgery is not an option if the cancer has spread or the tumor is large or hard to reach.  Often radiation therapy is given at the same time as chemotherapy.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "In the last few years, several new treatments were approved by the FDA, including the immunotherapy drugs durvalumab (Imfinzi) and tarlatamab (Imdelltra) and a new chemotherapy drug called lurbinectedin (Zepzelca).",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Many clinical trials in the works are studying treatments that may have better results for SCLC.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Here are some of the newest treatments.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "Targeted Therapies",
      "content": [
        "A promising new treatment option for SCLC is targeted therapy. Targeted therapy works by attacking specific cancer cells or blocking certain molecules that develop into cancer with minimal to no harm to normal cells.",
        "The benefit of targeted therapy is that it’s less toxic than standard treatments because it targets only the cancer cells or proteins involved in their growth. That may mean fewer side effects as well.",
        "Targeted therapy is still being studied for what works and what doesn’t. Scientists are looking at which genes to target in SCLC and which targeted therapies may work best to treat it. So far, results have been mixed for different targeted therapy drugs."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "A promising new treatment option for SCLC is targeted therapy. Targeted therapy works by attacking specific cancer cells or blocking certain molecules that develop into cancer with minimal to no harm to normal cells.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "The benefit of targeted therapy is that it’s less toxic than standard treatments because it targets only the cancer cells or proteins involved in their growth. That may mean fewer side effects as well.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Targeted therapy is still being studied for what works and what doesn’t. Scientists are looking at which genes to target in SCLC and which targeted therapies may work best to treat it. So far, results have been mixed for different targeted therapy drugs.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "Immunotherapy",
      "content": [
        "Another advancement in the treatment of SCLC is immunotherapy. This treatment helps your immune system fight cancer. Your immune system detects and kills foreign invaders, including cancers. Cancers have evolved to be very good at evading our immune system. Immunotherapy tries to enhance your natural immune response to cancer.",
        "For example, immune checkpoint inhibitors override your immune system's normal checks and balances so that your body creates an especially strong response to cancer cells."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "Another advancement in the treatment of SCLC is immunotherapy. This treatment helps your immune system fight cancer. Your immune system detects and kills foreign invaders, including cancers. Cancers have evolved to be very good at evading our immune system. Immunotherapy tries to enhance your natural immune response to cancer.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "For example, immune checkpoint inhibitors override your immune system's normal checks and balances so that your body creates an especially strong response to cancer cells.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": null,
      "content": [
        "Until recently, many advancements in treating lung cancer have centered on non-small-cell lung cancer (NSCLC). But new therapies for small-cell lung cancer (SCLC) have started to emerge, and the early results are promising.",
        "SCLC is an aggressive form of lung cancer, and new treatments are key for improving the outlook for people diagnosed with it.",
        "Right now, chemotherapy is the most common treatment for SCLC. There are other options, like surgery and radiation, but they’re limited and their use is controversial. For many people, surgery is not an option if the cancer has spread or the tumor is large or hard to reach.  Often radiation therapy is given at the same time as chemotherapy.",
        "In the last few years, several new treatments were approved by the FDA, including the immunotherapy drugs durvalumab (Imfinzi) and tarlatamab (Imdelltra) and a new chemotherapy drug called lurbinectedin (Zepzelca).",
        "Many clinical trials in the works are studying treatments that may have better results for SCLC.",
        "Here are some of the newest treatments."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "Until recently, many advancements in treating lung cancer have centered on non-small-cell lung cancer (NSCLC). But new therapies for small-cell lung cancer (SCLC) have started to emerge, and the early results are promising.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "SCLC is an aggressive form of lung cancer, and new treatments are key for improving the outlook for people diagnosed with it.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Right now, chemotherapy is the most common treatment for SCLC. There are other options, like surgery and radiation, but they’re limited and their use is controversial. For many people, surgery is not an option if the cancer has spread or the tumor is large or hard to reach.  Often radiation therapy is given at the same time as chemotherapy.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "In the last few years, several new treatments were approved by the FDA, including the immunotherapy drugs durvalumab (Imfinzi) and tarlatamab (Imdelltra) and a new chemotherapy drug called lurbinectedin (Zepzelca).",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Many clinical trials in the works are studying treatments that may have better results for SCLC.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Here are some of the newest treatments.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "Targeted Therapies",
      "content": [
        "A promising new treatment option for SCLC is targeted therapy. Targeted therapy works by attacking specific cancer cells or blocking certain molecules that develop into cancer with minimal to no harm to normal cells.",
        "The benefit of targeted therapy is that it’s less toxic than standard treatments because it targets only the cancer cells or proteins involved in their growth. That may mean fewer side effects as well.",
        "Targeted therapy is still being studied for what works and what doesn’t. Scientists are looking at which genes to target in SCLC and which targeted therapies may work best to treat it. So far, results have been mixed for different targeted therapy drugs."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "A promising new treatment option for SCLC is targeted therapy. Targeted therapy works by attacking specific cancer cells or blocking certain molecules that develop into cancer with minimal to no harm to normal cells.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "The benefit of targeted therapy is that it’s less toxic than standard treatments because it targets only the cancer cells or proteins involved in their growth. That may mean fewer side effects as well.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Targeted therapy is still being studied for what works and what doesn’t. Scientists are looking at which genes to target in SCLC and which targeted therapies may work best to treat it. So far, results have been mixed for different targeted therapy drugs.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "Immunotherapy",
      "content": [
        "Another advancement in the treatment of SCLC is immunotherapy. This treatment helps your immune system fight cancer. Your immune system detects and kills foreign invaders, including cancers. Cancers have evolved to be very good at evading our immune system. Immunotherapy tries to enhance your natural immune response to cancer.",
        "For example, immune checkpoint inhibitors override your immune system's normal checks and balances so that your body creates an especially strong response to cancer cells."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "Another advancement in the treatment of SCLC is immunotherapy. This treatment helps your immune system fight cancer. Your immune system detects and kills foreign invaders, including cancers. Cancers have evolved to be very good at evading our immune system. Immunotherapy tries to enhance your natural immune response to cancer.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "For example, immune checkpoint inhibitors override your immune system's normal checks and balances so that your body creates an especially strong response to cancer cells.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": null,
      "content": [
        "Immunotherapy for SCLC includes drugs like:",
        "Immunotherapy is often used along with chemotherapy to treat advanced SCLC.  In some cases, it may be given alone.",
        "Scientists hope to learn more about which patients may benefit from immunotherapy. To do this, they need to identify which biomarkers to look for that show the best results.",
        "Clinical trials are looking at how these drugs may help with SCLC."
      ],
      "bullets": [
        "Atezolizumab (Tecentriq)",
        "Atezolizumab and hyaluronidase-tqjs (Tecentriq Hybreza)",
        "Durvalumab (Imfinzi)",
        "Pembrolizumab (Keytruda)",
        "Tarlatamab (Imdelltra)"
      ],
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "Immunotherapy for SCLC includes drugs like:",
          "associated_bullets": [
            "Atezolizumab (Tecentriq)",
            "Atezolizumab and hyaluronidase-tqjs (Tecentriq Hybreza)",
            "Durvalumab (Imfinzi)",
            "Pembrolizumab (Keytruda)",
            "Tarlatamab (Imdelltra)"
          ]
        },
        {
          "type": "paragraph",
          "text": "Immunotherapy is often used along with chemotherapy to treat advanced SCLC.  In some cases, it may be given alone.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Scientists hope to learn more about which patients may benefit from immunotherapy. To do this, they need to identify which biomarkers to look for that show the best results.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Clinical trials are looking at how these drugs may help with SCLC.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "Radiotherapy",
      "content": [
        "Radiotherapy,  also known as radiation therapy , uses high levels of radiation to shrink tumors and kill cancer cells. Radiation therapy has been found to be effective in treating tumors in the chest.  It is often given at the same time as chemotherapy.  In some people, it is given after chemotherapy. In some people, radiation to the brain can be performed to help prevent SCLC from spreading to the brain. Radiosensitizers are drugs that speed up DNA damage and make free radicals to help kill cancer cells. Researchers have been studying certain drugs as radiosensitizers to see if they help make radiation therapy for SCLC more effective. More research is needed."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "Radiotherapy,  also known as radiation therapy , uses high levels of radiation to shrink tumors and kill cancer cells. Radiation therapy has been found to be effective in treating tumors in the chest.  It is often given at the same time as chemotherapy.  In some people, it is given after chemotherapy. In some people, radiation to the brain can be performed to help prevent SCLC from spreading to the brain. Radiosensitizers are drugs that speed up DNA damage and make free radicals to help kill cancer cells. Researchers have been studying certain drugs as radiosensitizers to see if they help make radiation therapy for SCLC more effective. More research is needed.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "Chemotherapy",
      "content": [
        "Metronomic chemotherapy is also called low-dose chemotherapy. It involves a lower dose of cancer drug given over a longer period of time. You may take it frequently, like every day or every week, for a long period of time. Or you may take it on an ongoing basis.",
        "This type of chemotherapy has fewer side effects than regular chemotherapy and may stop new blood vessels from growing, which may stop tumors from growing.",
        "Early use of it as a secondary treatment for SCLC has had positive results. Doctors are looking at it more closely to find out more about its possible toxicity.",
        "Lurbinectedin (Zepzelca) is a chemotherapy drug that damages the DNA of cancer cells and prevents them from dividing. The chemo may ultimately kill the cancer cells and your doctor may use it alone or with other drugs.",
        "But the FDA approved lurbinectedin to treat adults with metastatic SCLC in combination with immunotherapy medicines such as:",
        "This combination is for people who have SCLC that spread to other areas, then got worse when it was treated with platinum-based chemotherapy."
      ],
      "bullets": [
        "Atezolizumab (Tecentriq)",
        "Atezolizumab and hyaluronidase-tqjs (Tecentriq Hybreza)"
      ],
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "Metronomic chemotherapy is also called low-dose chemotherapy. It involves a lower dose of cancer drug given over a longer period of time. You may take it frequently, like every day or every week, for a long period of time. Or you may take it on an ongoing basis.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "This type of chemotherapy has fewer side effects than regular chemotherapy and may stop new blood vessels from growing, which may stop tumors from growing.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Early use of it as a secondary treatment for SCLC has had positive results. Doctors are looking at it more closely to find out more about its possible toxicity.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Lurbinectedin (Zepzelca) is a chemotherapy drug that damages the DNA of cancer cells and prevents them from dividing. The chemo may ultimately kill the cancer cells and your doctor may use it alone or with other drugs.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "But the FDA approved lurbinectedin to treat adults with metastatic SCLC in combination with immunotherapy medicines such as:",
          "associated_bullets": [
            "Atezolizumab (Tecentriq)",
            "Atezolizumab and hyaluronidase-tqjs (Tecentriq Hybreza)"
          ]
        },
        {
          "type": "paragraph",
          "text": "This combination is for people who have SCLC that spread to other areas, then got worse when it was treated with platinum-based chemotherapy.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": null,
      "content": [
        "Immunotherapy for SCLC includes drugs like:",
        "Immunotherapy is often used along with chemotherapy to treat advanced SCLC.  In some cases, it may be given alone.",
        "Scientists hope to learn more about which patients may benefit from immunotherapy. To do this, they need to identify which biomarkers to look for that show the best results.",
        "Clinical trials are looking at how these drugs may help with SCLC."
      ],
      "bullets": [
        "Atezolizumab (Tecentriq)",
        "Atezolizumab and hyaluronidase-tqjs (Tecentriq Hybreza)",
        "Durvalumab (Imfinzi)",
        "Pembrolizumab (Keytruda)",
        "Tarlatamab (Imdelltra)"
      ],
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "Immunotherapy for SCLC includes drugs like:",
          "associated_bullets": [
            "Atezolizumab (Tecentriq)",
            "Atezolizumab and hyaluronidase-tqjs (Tecentriq Hybreza)",
            "Durvalumab (Imfinzi)",
            "Pembrolizumab (Keytruda)",
            "Tarlatamab (Imdelltra)"
          ]
        },
        {
          "type": "paragraph",
          "text": "Immunotherapy is often used along with chemotherapy to treat advanced SCLC.  In some cases, it may be given alone.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Scientists hope to learn more about which patients may benefit from immunotherapy. To do this, they need to identify which biomarkers to look for that show the best results.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Clinical trials are looking at how these drugs may help with SCLC.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "Radiotherapy",
      "content": [
        "Radiotherapy,  also known as radiation therapy , uses high levels of radiation to shrink tumors and kill cancer cells. Radiation therapy has been found to be effective in treating tumors in the chest.  It is often given at the same time as chemotherapy.  In some people, it is given after chemotherapy. In some people, radiation to the brain can be performed to help prevent SCLC from spreading to the brain. Radiosensitizers are drugs that speed up DNA damage and make free radicals to help kill cancer cells. Researchers have been studying certain drugs as radiosensitizers to see if they help make radiation therapy for SCLC more effective. More research is needed."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "Radiotherapy,  also known as radiation therapy , uses high levels of radiation to shrink tumors and kill cancer cells. Radiation therapy has been found to be effective in treating tumors in the chest.  It is often given at the same time as chemotherapy.  In some people, it is given after chemotherapy. In some people, radiation to the brain can be performed to help prevent SCLC from spreading to the brain. Radiosensitizers are drugs that speed up DNA damage and make free radicals to help kill cancer cells. Researchers have been studying certain drugs as radiosensitizers to see if they help make radiation therapy for SCLC more effective. More research is needed.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "Chemotherapy",
      "content": [
        "Metronomic chemotherapy is also called low-dose chemotherapy. It involves a lower dose of cancer drug given over a longer period of time. You may take it frequently, like every day or every week, for a long period of time. Or you may take it on an ongoing basis.",
        "This type of chemotherapy has fewer side effects than regular chemotherapy and may stop new blood vessels from growing, which may stop tumors from growing.",
        "Early use of it as a secondary treatment for SCLC has had positive results. Doctors are looking at it more closely to find out more about its possible toxicity.",
        "Lurbinectedin (Zepzelca) is a chemotherapy drug that damages the DNA of cancer cells and prevents them from dividing. The chemo may ultimately kill the cancer cells and your doctor may use it alone or with other drugs.",
        "But the FDA approved lurbinectedin to treat adults with metastatic SCLC in combination with immunotherapy medicines such as:",
        "This combination is for people who have SCLC that spread to other areas, then got worse when it was treated with platinum-based chemotherapy."
      ],
      "bullets": [
        "Atezolizumab (Tecentriq)",
        "Atezolizumab and hyaluronidase-tqjs (Tecentriq Hybreza)"
      ],
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "Metronomic chemotherapy is also called low-dose chemotherapy. It involves a lower dose of cancer drug given over a longer period of time. You may take it frequently, like every day or every week, for a long period of time. Or you may take it on an ongoing basis.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "This type of chemotherapy has fewer side effects than regular chemotherapy and may stop new blood vessels from growing, which may stop tumors from growing.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Early use of it as a secondary treatment for SCLC has had positive results. Doctors are looking at it more closely to find out more about its possible toxicity.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Lurbinectedin (Zepzelca) is a chemotherapy drug that damages the DNA of cancer cells and prevents them from dividing. The chemo may ultimately kill the cancer cells and your doctor may use it alone or with other drugs.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "But the FDA approved lurbinectedin to treat adults with metastatic SCLC in combination with immunotherapy medicines such as:",
          "associated_bullets": [
            "Atezolizumab (Tecentriq)",
            "Atezolizumab and hyaluronidase-tqjs (Tecentriq Hybreza)"
          ]
        },
        {
          "type": "paragraph",
          "text": "This combination is for people who have SCLC that spread to other areas, then got worse when it was treated with platinum-based chemotherapy.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "The Future of SCLC Treatment",
      "content": [
        "More clinical trials are needed to better understand newer therapies like immunotherapy and other drugs.",
        "Experts hope to learn more about different options for using these therapies, like which combinations work and how to predict which patients they’ll work best for.",
        "There are many drugs being studied now, including newer, emerging drugs.",
        "Even though progress has been somewhat slow over the last few decades, there’s now new activity that may lead to promising new ways of treating this aggressive form of lung cancer."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "More clinical trials are needed to better understand newer therapies like immunotherapy and other drugs.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Experts hope to learn more about different options for using these therapies, like which combinations work and how to predict which patients they’ll work best for.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "There are many drugs being studied now, including newer, emerging drugs.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Even though progress has been somewhat slow over the last few decades, there’s now new activity that may lead to promising new ways of treating this aggressive form of lung cancer.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "What You Can Do Now",
      "content": [
        "With many clinical trials now in effect, there may be one you can get involved in. Some are funded by the U.S. government and others are supported by private sources.",
        "For more information, talk to your doctor or go to clinicaltrials.gov. You can also find clinical trials at the NIH Clinical Center at cc.nih.gov. For details on privately funded clinical trials, go to centerwatch.com.",
        "While clinical trials continue, you can get involved in advocacy efforts to help move SCLC advancements forward. The more people with SCLC who participate in research opportunities, the more we will learn about useful treatments."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "With many clinical trials now in effect, there may be one you can get involved in. Some are funded by the U.S. government and others are supported by private sources.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "For more information, talk to your doctor or go to clinicaltrials.gov. You can also find clinical trials at the NIH Clinical Center at cc.nih.gov. For details on privately funded clinical trials, go to centerwatch.com.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "While clinical trials continue, you can get involved in advocacy efforts to help move SCLC advancements forward. The more people with SCLC who participate in research opportunities, the more we will learn about useful treatments.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "The Future of SCLC Treatment",
      "content": [
        "More clinical trials are needed to better understand newer therapies like immunotherapy and other drugs.",
        "Experts hope to learn more about different options for using these therapies, like which combinations work and how to predict which patients they’ll work best for.",
        "There are many drugs being studied now, including newer, emerging drugs.",
        "Even though progress has been somewhat slow over the last few decades, there’s now new activity that may lead to promising new ways of treating this aggressive form of lung cancer."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "More clinical trials are needed to better understand newer therapies like immunotherapy and other drugs.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Experts hope to learn more about different options for using these therapies, like which combinations work and how to predict which patients they’ll work best for.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "There are many drugs being studied now, including newer, emerging drugs.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Even though progress has been somewhat slow over the last few decades, there’s now new activity that may lead to promising new ways of treating this aggressive form of lung cancer.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "What You Can Do Now",
      "content": [
        "With many clinical trials now in effect, there may be one you can get involved in. Some are funded by the U.S. government and others are supported by private sources.",
        "For more information, talk to your doctor or go to clinicaltrials.gov. You can also find clinical trials at the NIH Clinical Center at cc.nih.gov. For details on privately funded clinical trials, go to centerwatch.com.",
        "While clinical trials continue, you can get involved in advocacy efforts to help move SCLC advancements forward. The more people with SCLC who participate in research opportunities, the more we will learn about useful treatments."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "With many clinical trials now in effect, there may be one you can get involved in. Some are funded by the U.S. government and others are supported by private sources.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "For more information, talk to your doctor or go to clinicaltrials.gov. You can also find clinical trials at the NIH Clinical Center at cc.nih.gov. For details on privately funded clinical trials, go to centerwatch.com.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "While clinical trials continue, you can get involved in advocacy efforts to help move SCLC advancements forward. The more people with SCLC who participate in research opportunities, the more we will learn about useful treatments.",
          "associated_bullets": null
        }
      ]
    }
  ],
  "pdfs": [],
  "images": [
    "https://img.lb.wbmdstatic.com/vim/live/webmd/consumer_assets/site_images/logos/webmd/web/webmd-logo-fb.jpg",
    "https://img.wbmdstatic.com/vim/live/webmd/consumer_assets/site_images/logos/webmd/web/webmd_logo_white.svg",
    "https://img.lb.wbmdstatic.com/vim/live/webmd/consumer_assets/site_images/articles/biographies/kara-mayer-robinson-382x382.jpg?resize=51px:51px&output-quality=75",
    "https://img.lb.wbmdstatic.com/vim/live/webmd/consumer_assets/site_images/articles/biographies/avatar_placeholder.jpg?resize=51px:51px&output-quality=75",
    "https://img.lb.wbmdstatic.com/vim/live/webmd/consumer_assets/site_images/article_thumbnails/hpt_toc_redesign/more_on/MoreOn_HeartburnGerd.jpg?resize=300px:*&output-quality=75",
    "https://img.lb.wbmdstatic.com/vim/live/webmd/consumer_assets/site_images/article_thumbnails/hpt_toc_redesign/hpt_toc_redesign_illustrations/1500x1500_overview_and_facts_option_3.jpg?resize=500px:*&output-quality=75",
    "https://privacy-policy.truste.com/privacy-seal/seal?rid=07326333-3522-463d-81bf-f00fd7171fff",
    "https://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/layout/shared/tag-registered.png?resize=*:60px",
    "https://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/oncology/1/footer-images/ad-choice.png",
    "https://img.wbmdstatic.com/vim/live/webmd/consumer_assets/site_images/oncology/1/images/webmd-logo-white.svg",
    "https://sb.scorecardresearch.com/p?c1=2&c2=6035829&cv=3.6&cj=1"
  ],
  "related_links": [],
  "sources": [
    "Clinical Cancer Research: “ Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study.”",
    "International Journal of Radiation Oncology : “Identifying Novel Epigenetic Radiosensitizers in Small Cell Lung Cancer Using a Custom EpiDrug CRISPR Screen.”",
    "Journal of Hematology & Oncology : “Emerging therapies for small cell lung cancer.”",
    "OncoTargets and Therapy : “Immune checkpoint inhibitors for small cell lung cancer: opportunities and challenges.”",
    "Targeted Oncology : “Benefit of Lurbinectedin to be Confirmed in Randomized, Phase 3 Clinical Trial.”",
    "American Journal of Managed Care: “SCLC Treatment: Current Landscape and Hope for the Future.”",
    "Cancer Treatment Centers of America: “Lung Cancer Stages.”",
    "National Cancer Institute: “Immunotherapy to Treat Cancer,” “Lurbinectedin,” “Metronomic Chemotherapy,” “Radiation Therapy to Treat Cancer.”",
    "NORD: “Small Cell Lung Cancer.”",
    "Yale Medicine: “Small Cell Lung Cancer.”"
  ],
  "meta_description": "What are the latest advances in small-cell lung cancer treatment? See how far we’ve come and what’s on the horizon.",
  "canonical_url": "https://www.webmd.com/lung-cancer/advances-small-cell-lung-cancer-treatment",
  "tags": [
    "Health Topics",
    "WebMD"
  ],
  "scrape_timestamp_utc": "2026-01-23T03:47:56.334694Z"
}